Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB26FNMNR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,129
Award facts
- Contract value 100% obligated
- $19,129.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,129.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy that establishes regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program (contract SPE2DR) with a ceiling value of $499,999,999 and a completion date of December 31, 2036, structured to enable the company to serve as a critical pharmaceutical supplier for DoD healthcare operations globally. The contractor's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, with the current delivery order for Entyvio representing one of numerous orders issued by the Defense Logistics Agency's Medical Supply Chain division to fulfill recurring pharmaceutical requirements across the military medical system.
Quick answers
Who was awarded contract SPE2DB26FNMNR?
SPE2DB26FNMNR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FNMNR worth?
The government has obligated $19,129 on SPE2DB26FNMNR.
Is contract SPE2DB26FNMNR an order under another contract?
Yes. SPE2DB26FNMNR is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMNR competed?
The extent of competition for SPE2DB26FNMNR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award